Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part I: studies in water

Arginine vasopressin (AVP) and mesotocin (MT) belong to the neurohypophyseal hormone family. The former plays a very important role in the control of urine concentration and the blood pressure in mammals, whereas the latter stimulates uterine concentration and initiates birth in amphibians, marsupials, wallabies, birds, and fishes. Analysis of their 3D structure could be helpful for understanding the evolutionary relationship between all vasopressin‐ and oxytocin‐like hormones. In addition, it allows design of new analogs with appropriate biological activity for humans and animals. In this paper, we present the conformational studies of AVP and MT, under the aqueous conditions. In our investigations, we used 2D NMR spectroscopy and time‐averaged molecular dynamics calculations in explicit water. Our studies have shown that both peptides, despite displaying a high sequence homology, differ from each other with regard to the three‐dimensional structure. They are in conformational equilibrium as a result of the cis/trans isomerization across the Cys6–Pro7 peptide bond. Both peptides form β‐turns in their cyclic part, wherein the C‐terminal fragment of MT is bent, whereas that of AVP is extended. Copyright © 2007 European Peptide Society and John Wiley & Sons, Ltd.

[1]  S. Jard,et al.  Specific binding of (3H) lysine-vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation. , 1973, The Journal of biological chemistry.

[2]  A. F. Muller,et al.  Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. , 1986, Molecular pharmacology.

[3]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[4]  A. Bax,et al.  1H and13C Assignments from Sensitivity-Enhanced Detection of Heteronuclear Multiple-Bond Connectivity by 2D Multiple Quantum NMR , 1986 .

[5]  A Sánchez-Ferrer,et al.  Software for reviewing biomolecules in three dimensions on the Internet. , 1995, Trends in biochemical sciences.

[6]  Kozminski.  The new active-coupling-pattern tilting experiment for an efficient and accurate determination of homonuclear coupling constants , 1998, Journal of magnetic resonance.

[7]  B. A. Baldwin,et al.  Intracerebroventricular oxytocin stimulates maternal behaviour in the sheep. , 1987, Neuroendocrinology.

[8]  K. Wüthrich,et al.  Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. , 1983, Biochemical and biophysical research communications.

[9]  H. Vaudry,et al.  Effects of central and peripheral administration of arginine vasotocin and related neuropeptides on blood pressure and heart rate in the conscious trout , 1993, Brain Research.

[10]  K Wüthrich,et al.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules , 1995, Journal of biomolecular NMR.

[11]  R. Acher,et al.  Man and the chimaera. Selective versus neutral oxytocin evolution. , 1995, Advances in experimental medicine and biology.

[12]  B. Berkowitz,et al.  Characterization of vasopressin analgesia. , 1982, The Journal of pharmacology and experimental therapeutics.

[13]  Ernest D. Laue,et al.  The Sensitivity of Experiments Which Use Gradient Pulses for Coherence-Pathway Selection , 1994 .

[14]  Paul A. Keifer,et al.  Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity , 1992 .

[15]  Cezary Czaplewski,et al.  Molecular modeling of the human vasopressin V2 receptor/agonist complex , 1998, J. Comput. Aided Mol. Des..

[16]  R. Hodges,et al.  Effect of trifluoroethanol on the solution structure and flexibility of desmopressin: a two-dimensional NMR study. , 2009, International journal of peptide and protein research.

[17]  J. M. Ree,et al.  Effect of neurohypophyseal hormones on morphine dependence , 1977, Psychoneuroendocrinology.

[18]  S. Kohno,et al.  Molecular cloning of an anuran V(2) type [Arg(8)] vasotocin receptor and mesotocin receptor: functional characterization and tissue expression in the Japanese tree frog (Hyla japonica). , 2003, General and comparative endocrinology.

[19]  Combined use of NMR, distance geometry, and restrained energy minimization for the conformational analysis of 8-lysine–vasopressin , 1992 .

[20]  N. Fineberg,et al.  Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. , 1988, Clinical science.

[21]  M. Billeter,et al.  Calibration of the angular dependence of the amide proton-Cα proton coupling constants, 3JHNα, in a globular protein: Use of 3JHNα for identification of helical secondary structure , 1984 .

[22]  A. Liwo,et al.  Conformational analysis of [Cpp1, Sar7, Arg8] vasopressin by 1H-NMR spectroscopy and molecular mechanics calculations. , 2009, International journal of peptide and protein research.

[23]  J. Rose,et al.  Structures of an unliganded neurophysin and its vasopressin complex: Implications for binding and allosteric mechanisms , 2001, Protein science : a publication of the Protein Society.

[24]  R. Bhaskaran,et al.  Conformational properties of oxytocin in dimethyl sulfoxide solution: NMR and restrained molecular dynamics studies , 1992, Biopolymers.

[25]  K. Wüthrich,et al.  Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.

[26]  Structure determination of a tetrasaccharide: transient nuclear Overhauser effects in the rotating frame , 1984 .

[27]  R. van Kesteren,et al.  Evolution of the vasopressin/oxytocin superfamily: characterization of a cDNA encoding a vasopressin-related precursor, preproconopressin, from the mollusc Lymnaea stagnalis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Abraham Nudelman,et al.  NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities. , 1997, The Journal of organic chemistry.

[29]  C. Larive,et al.  Cis/trans conformational equilibrium across the cysteine6-proline peptide bond of oxytocin, arginine vasopressin, and lysine vasopressin , 1992 .

[30]  M. Williamson,et al.  Structure determination of [Arg8]vasopressin methylenedithioether in dimethylsulfoxide using NMR. , 2000, European journal of biochemistry.

[31]  M. Wilkinson,et al.  The antipyretic effects of centrally administered vasopressin at different ambient temperatures , 1987, Brain Research.

[32]  Bi-Cheng Wang,et al.  Crystal structure of the neurophysin—oxytocin complex , 1996, Nature Structural Biology.

[33]  R. Hodges,et al.  1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects , 1995, Journal of biomolecular NMR.

[34]  D. G. Davis,et al.  Practical aspects of two-dimensional transverse NOE spectroscopy , 1985 .

[35]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[36]  T. Insel,et al.  Voles and vasopressin: a review of molecular, cellular, and behavioral studies of pair bonding and paternal behaviors. , 1998, Progress in brain research.

[37]  E. Tribollet,et al.  Vasopressin and oxytocin receptors in the central nervous system. , 1996, Critical reviews in neurobiology.

[38]  B. Bohus,et al.  Attenuation by arginine- and desglycinamide-lysine-vasopressin of a centrally evoked pressor response. , 1982, Journal of the autonomic nervous system.

[39]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[40]  V. Pattabhi,et al.  Trypsin inhibition by a peptide hormone: crystal structure of trypsin-vasopressin complex. , 2005, Journal of molecular biology.

[41]  J. Kihlberg,et al.  Conformation of desmopressin, an analogue of the peptide hormone vasopressin, in aqueous solution as determined by NMR spectroscopy. , 1998, European journal of biochemistry.

[42]  R. Hughes,et al.  Structure of pressinoic acid: the cyclic moiety of vasopressin. , 1986, Science.

[43]  L. Parry,et al.  Up-Regulation of Mesotocin Receptors in the Tammar Wallaby Myometrium Is Pregnancy-Specific and Independent of Estrogen1 , 2002, Biology of reproduction.

[44]  R. Ślusarz,et al.  Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors—molecular dynamics study of the activated receptor–vasopressin–Gα systems , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[45]  S. Rodziewicz-Motowidło,et al.  Conformational solution studies of [Sar7]desamino‐ and [MeAla7]desamino‐ vasopressin analogues using NMR spectroscopy , 2002, Journal of peptide science : an official publication of the European Peptide Society.

[46]  K Wüthrich,et al.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.

[47]  T. Blundell,et al.  The conformation of deamino-oxytocin: X-ray analysis of the 'dry' and 'wet' forms. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[48]  H. Sterk,et al.  Assignment of proton NMR resonances and conformational analysis of [Lys8]‐vasopressin homologues , 1991 .

[49]  P. Marks,et al.  Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens , 1994, Peptides.

[50]  V. Hruby,et al.  Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. , 1981, Biochemistry.

[51]  J. Blankenship,et al.  Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]‐OT and [dPen1,Pen6, 5‐tBuPro7]‐OT by NMR, raman, CD spectroscopy and molecular modeling , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[52]  V J Hruby,et al.  Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods. , 1998, Biopolymers.

[53]  E. Grishin,et al.  Three-dimensional structure of ectatomin from Ectatomma tuberculatum ant venom , 1995, Journal of biomolecular NMR.

[54]  L. Parry,et al.  Mesotocin receptor gene and protein expression in the prostate gland, but not testis, of the tammar wallaby, Macropus eugenii. , 1998, Biology of reproduction.

[55]  V. Hruby,et al.  Laser Raman spectroscopy and circular dichroism studies of the peptide hormones mesotocin, vasotocin, lysine vasopressin, and arginine vasopressin. Conformational analysis. , 1979, The Journal of biological chemistry.

[56]  R. Ślusarz,et al.  Conformational studies of highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 vasopressin agonists , 2008 .

[57]  T. Blundell,et al.  Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. , 1988, Science.

[58]  E. Kojro,et al.  Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. , 1991, European journal of biochemistry.